Medicare & Medicaid
Patient demand could result in expanded coverage, but it could cost the federal program between $13.6 and $26.8 billion annually.
As a catalyst for the renewed push, lawmakers cited the lives lost during the COVID-19 pandemic.
Medicare annual spending on lecanemab's medication costs alone would place it among the most expensive Part B medications.
Humana framed the partnerships as part of a push to expand value-based care across its slate of home health services.
The requirements would result in federal savings, but would pass costs on to states and cause large coverage losses, data shows.
The partnership will launch in South Carolina and Georgia this year and then expand to five more states in 2024.
Out of the improper payments, $348 million were for telehealth-based psychotherapy services.
The growth in enrollment is due to a number of factors, said KFF, including the attraction of extra benefits offered by most plans.
CMS will conduct preview calls for the 2024 MIPS performance period until June 2, with May 19 being the last day to request a call.
The proposed rules would establish wait times and require states to disclose provider payment rates in fee-for-service and managed care.